Felodipine and Multihance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Felodipine (felodipine) and Multihance (gadobenate dimeglumine). Common drug interactions include arthralgia among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Felodipine and Multihance. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Felodipine?

Felodipine has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 15,120 Felodipine users. Check the latest studies of Felodipine.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

On Jul, 14, 2026

17 people who take Felodipine and Multihance together, and have interactions are studied.

Felodipine and Multihance drug interactions.

What are the common drug interactions of Felodipine and Multihance, by gender? *:

female:

Arthralgia (joint pain)
Asthenia (weakness)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Pruritus (severe itching of the skin)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Peau d'orange (orange peel skin)
Dry skin
Skin disorder (skin disease)
Lichenification (thickening and hardening of the skin)
Pain in extremity
Pigmentation disorder (disturbances of human skin colour)
Pulmonary function test decreased

What are the common drug interactions of Felodipine and Multihance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin swelling
Skin tightness
Oedema peripheral (superficial swelling)
Skin nodule (slightly elevated lesions on or in the skin)
Arthralgia (joint pain)
Asthenia (weakness)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance

40-49:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Deformity (disfigurement)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Joint swelling
Mobility decreased (ability to move is reduced)
Myosclerosis (hardening of muscle tissue)

50-59:

n/a

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin tightness
Lichenification (thickening and hardening of the skin)
Oedema peripheral (superficial swelling)
Pigmentation disorder (disturbances of human skin colour)
Pulmonary function test decreased
Rash
Skin exfoliation (removal of the oldest dead skin cells)
Skin fibrosis (fibrous tissue formation on skin)

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 29.41%
Cardiac Failure Congestive: 5 people, 29.41%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Felodipine and Multihance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously